Jimmy Shan

Stock Analyst at RBC Capital

(3.36)

# 930

Out of 4,784 analysts

13

Total ratings

64.29%

Success rate

13.54%

Average return

Main Sectors:

Healthcare Real Estate

Top Industries:

Biotechnology Real Estate Services

Stocks Rated by Jimmy Shan

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TRML Tourmaline Bio	Initiates: Outperform	$58	$16.65	+248.35%	1	Feb 24, 2025
	CIGI Colliers International Group	Maintains: Outperform	$170 → $175	$120.19	+45.60%	12	Feb 7, 2025

Tourmaline Bio

Feb 24, 2025

Initiates: Outperform

Price Target: $58

Current: $16.65

Upside: +248.35%

Colliers International Group

Feb 7, 2025

Maintains: Outperform

Price Target: $170 → $175

Current: $120.19

Upside: +45.60%